Red yeast rice | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chinese name | |||||||||||||||
Traditional Chinese | 紅麴米 | ||||||||||||||
Simplified Chinese | 红曲米 | ||||||||||||||
Literal meaning | red yeast rice | ||||||||||||||
| |||||||||||||||
Japanese name | |||||||||||||||
Hiragana | べにこうじ | ||||||||||||||
|
Red yeast rice or red rice koji is a bright reddish purple fermented rice, which acquires its color from being cultivated with the mold Monascus purpureus. Red yeast rice is what is referred to as a kōji in Japanese, meaning "grain or bean overgrown with a mold culture", a food preparation tradition going back to ca. 300 BC.[1]
In addition to its culinary use, red yeast rice is also used in Chinese herbology and Traditional Chinese medicine, possibly during the Tang dynasty around AD 800. Red yeast rice is described in the Chinese pharmacopoeia Ben Cao Gang Mu by Li Shizhen.[2][3]
A modern-era use as a dietary supplement developed in the late 1970s after researchers were isolating lovastatin from Aspergillus and monacolins from Monascus, the latter being the same fungus used to make red yeast rice. Chemical analysis soon showed that lovastatin and monacolin K were identical. Lovastatin became the patented prescription drug Mevacor.[4] Red yeast rice went on to become a non-prescription dietary supplement in the United States and other countries. In 1998, the U.S. Food and Drug Administration (FDA) initiated action to ban a dietary supplement containing red yeast rice extract, stating that red yeast rice products containing monacolin K are identical to a prescription drug, and thus subject to regulation as a drug.[5]
Erdogrul2004
was invoked but never defined (see the help page).Song2019
was invoked but never defined (see the help page).Duggan1989
was invoked but never defined (see the help page).Pharmanex2001
was invoked but never defined (see the help page).